HAE
Haemonetics Corporation
75.38
5 x 75.12
1 x 75.26
bid
ask
+
0.53
0.71%
11:24 AM
timesize
| Ytd | -5.95% | |
| 1y | -1.13% |
74.69
day range
75.98
47.32
52 week range
87.32
| Open | 75.43 | Prev Close | 74.85 | Low | 74.69 | High | 75.98 | Mkt Cap | 3.43B |
| Vol | 138.87K | Avg Vol | 895.38K | EPS | 2.05 | P/E | 36.80 | Forward P/E | 13.00 |
| Beta | 0.54 | Short Ratio | 2.90 | Inst. Own | 108.25% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 65.73 | 200-d Avg | 64.65 | 1yr Est | 85.20 |
| Income Statement | |||
| Total Revenue | 346.35M | ||
| Revenues (USD) | 346.35M | ||
| Cost of Revenue | 148.14M | ||
| Gross Profit | 198.21M | ||
| Operating Expenses | 223.12M | ||
| Research and Development Expense | 14.45M | ||
| Selling, General and Administrative Expense | 120.93M | ||
| Operating Income | -24.90M | ||
| Interest Expense | 5.37M | ||
| Income Tax Expense | -8.25M | ||
| Net Income | -20.15M | ||
| Net Income Common Stock | -20.15M | ||
| Net Income Common Stock (USD) | -20.15M | ||
| Consolidated Income | -20.15M | ||
| Earnings per Basic Share | -0.41 | ||
| Earnings per Basic Share (USD) | -0.41 | ||
| Earnings per Diluted Share | -0.41 | ||
| Earning Before Interest & Taxes (EBIT) | -23.02M | ||
| Earning Before Interest & Taxes (USD) | -23.02M | ||
| Weighted Average Shares | 46.23M | ||
| Weighted Average Shares Diluted | 46.41M | ||
| Balance Sheet | |||
| Cash and Equivalents | 245.44M | ||
| Cash and Equivalents (USD) | 245.44M | ||
| Trade and Non-Trade Receivables | 216.86M | ||
| Current Assets | 834.88M | ||
| Property, Plant & Equipment Net | 305.76M | ||
| Total Assets | 2.40B | ||
| Debt Current | 5.01M | ||
| Total Debt | 1.22B | ||
| Current Liabilities | 282.60M | ||
| Debt Non-Current | 1.22B | ||
| Total Liabilities | 1.60B | ||
| Accumulated Retained Earnings (Deficit) | 279.34M | ||
| Accumulated Other Comprehensive Income | -37.61M | ||
| Shareholders Equity | 796.32M | ||
| Shareholders Equity (USD) | 796.32M | ||
| Assets Non-Current | 1.56B | ||
| Total Debt (USD) | 1.22B | ||
| Goodwill and Intangible Assets | 1.10B | ||
| Inventory | 306.37M | ||
| Liabilities Non-Current | 1.32B | ||
| Trade and Non-Trade Payables | 51.06M | ||
| Tax Assets | 9.52M | ||
| Tax Liabilities | 38.05M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 27.32M | ||
| Net Cash Flow from Financing | -101.50M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -117.93M | ||
| Capital Expenditure | -26.43M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -60.18M | ||
| Issuance (Purchase) of Equity Shares | -99.92M | ||
| Issuance (Repayment) of Debt Securities | -1.56M | ||
| Net Cash Flow from Investing | -86.61M | ||
| Net Cash Flow from Operations | 70.94M | ||
| Effect of Exchange Rate Changes on Cash | -756.00K | ||
| Share Based Compensation | 9.13M | ||